Imatinib Enhances Functional Outcome after Spinal Cord Injury

We investigated whether imatinib (Gleevec®, Novartis), a tyrosine kinase inhibitor, could improve functional outcome in experimental spinal cord injury. Rats subjected to contusion spinal cord injury were treated orally with imatinib for 5 days beginning 30 minutes after injury. We found that imatin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Abrams, Mathew B., Nilsson, Ingrid, Lewandowski, Sebastian A., Kjell, Jacob, Codeluppi, Simone, Olson, Lars, Eriksson, Ulf
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2012
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3378614/
https://ncbi.nlm.nih.gov/pubmed/22723886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0038760
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi